Skip to content

Cell-free DNA (cfDNA) quantitative measurement using a specific nucleic acid probe for a particular genetic marker (e.g., tumor-associated or inherited variant)

Published: August 9, 2026Updated: August 16, 2026

This test measures tiny fragments of DNA found naturally in your blood, which can sometimes come from tumors or other conditions. It uses a specialized probe to detect specific genetic sequences.

Quick summary

["This test helps identify certain genetic markers that may indicate conditions like cancer or genetic predispositions."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
101816-7
Short code
CMV DNA Ur NAA+probe-aCnc
Synonyms
CMV DNA Ur NAA+probe-aCnc
Category
chemistry
Sample
urine
Container
Sterile urine container
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
probe-amp-tar
Specimen volume
10 mL
Stability
Room temperature: 2h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
4–24 hours
Order
routine

How the Test Works

Your blood sample is collected and processed to extract cell-free DNA (cfDNA). A specialized probe targets a specific genetic sequence, allowing the test to detect its presence with high sensitivity. The result reflects the concentration of this DNA fragment in your bloodstream.

What to Expect Before the Test

No special preparation is needed for this test. You may have a simple blood draw, similar to other routine blood tests. If you’re taking medications or have certain health conditions, let your healthcare provider know before the test.

Possible Uses and Benefits

This test may be used in research, early cancer detection, or monitoring certain genetic conditions. It can provide insights into genetic variations that might not be detected by standard blood tests alone.

What the Results Mean

Results are qualitative (present or absent) for the specific probe sequence. A positive result means the probe detected the targeted genetic sequence, which may warrant further evaluation by a healthcare professional.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance

Short name

cfDNA Probe Test

Frequently asked questions

Why might my doctor order this test?
Your doctor may recommend this test if you have a family history of certain genetic conditions, are part of a clinical trial, or if you’re being monitored for conditions where specific genetic markers are relevant (e.g., hereditary cancer syndromes). It can help identify genetic markers that may influence health risks or treatment options.
What if the test is positive?
A positive result means the targeted genetic sequence was detected. This finding may prompt additional testing, genetic counseling, or further evaluation by a specialist to understand its implications for your health. Your doctor will discuss next steps based on your individual situation.
How often should I get this test?
The frequency of this test depends entirely on your medical needs. Your healthcare provider will determine how often you should be tested, whether it’s part of routine monitoring, research participation, or as part of a specific diagnostic process.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy